Stay updated with breaking news from 46433010. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) EVP Eric Swayze sold 10,773 shares of the stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $52.00, for a total transaction of $560,196.00. Following the transaction, the executive vice president now owns 32,516 shares in the company, valued […]
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) have received a consensus rating of “Moderate Buy” from the fourteen research firms that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell rating, four have given a hold rating, seven have given a buy rating and one […]
StockNews.com upgraded shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) from a sell rating to a hold rating in a research note released on Tuesday. Other analysts also recently issued reports about the stock. Raymond James initiated coverage on shares of Ionis Pharmaceuticals in a research report on Thursday, September 28th. They set a strong-buy […]
StockNews.com upgraded shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) from a sell rating to a hold rating in a report published on Tuesday. IONS has been the subject of a number of other reports. The Goldman Sachs Group increased their price target on Ionis Pharmaceuticals from $25.00 to $28.00 and gave the company a […]
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) had its target price hoisted by Piper Sandler from $60.00 to $62.00 in a research note issued on Thursday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Piper Sandler’s target price points to a potential upside of 21.62% from the company’s current price. Several […]